SCHEMBL31565884

SCHEMBL31565884

NS(=O)(=O)CC(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPE Q05469 1/20 0.43
▸ ESR1 P03372 2/20 0.42
▸ ESR2 Q92731 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ GHSR Q92847 1/20 0.39
▸ ABHD6 Q9BV23 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CPT2 P23786 1/20 0.39
▸ CPT1A P50416 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ SCN9A Q15858 2/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565953 0.90 ALDH1A1 (0.43) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL31566058 0.89 ESR1 (0.45) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL31565894 0.87 NPC1 (0.44) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL31565889 0.86 ESR1 (0.47) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL31565864 0.85 S1PR1 (0.46) LIPEESR1ESR2L3MBTL1GHSR
SCHEMBL31565857 0.85 LIPE (0.45) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL31565900 0.84 LIPE (0.47) LIPEESR1ESR2GHSRABHD6
SCHEMBL31565924 0.84 S1PR1 (0.45) LIPEESR1ESR2ALDH1A1L3MBTL1
SCHEMBL25968671 0.83 ESR1 (0.43) LIPEESR1ESR2ALDH1A1GHSR
SCHEMBL3989312 0.83 LIPE (0.48) LIPEESR1ESR2GHSRABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 LIPE 4593/4885ESR1 998/4885ESR2 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback